PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 2026Case Reports in Oncological Medicine0 citationsOpen Access

Isolated Metachronous Splenic Metastasis of Lung Adenocarcinoma: Long‐Term Survival After Splenectomy

View Full Paper
NWNina WittlinMBMartin Buess

Key Points

  • To evaluate the outcomes of splenectomy in a patient with isolated splenic metastasis from lung adenocarcinoma.
  • Reported a case of a 66-year-old female with isolated splenic metastasis after lung cancer resection.
  • Conducted diagnostic and therapeutic splenectomy.
  • Followed up the patient for 14 years post-surgery.
  • The patient remained tumor-free for 14 years after undergoing splenectomy.
  • This report describes the longest survival recorded following isolated splenic metastasis from lung cancer.

Abstract

Metastasis to the spleen is an uncommon finding in lung cancer and is typically associated with multivisceral disseminated disease. Isolated splenic metastasis in patients with lung cancer is exceedingly rare, with only 50 cases reported in the literature. We report a case of an asymptomatic, metachronous, isolated splenic metastasis in a 66‐year‐old female patient diagnosed 18 months after resection of lung adenocarcinoma. The patient underwent diagnostic and therapeutic splenectomy and remained tumor‐free for 14 years. To our knowledge, this represents the longest reported survival following an isolated splenic metastasis from lung cancer. This case suggests that in well‐selected patients with isolated splenic involvement, aggressive local therapy such as splenectomy can be curative and may lead to exceptional long‐term survival.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wittlin et al. (2026) studied this question.

synapsesocial.com/papers/69e473de010ef96374d8f971https://doi.org/10.1155/crom/1635762
Ask AI
Helpful
Bookmark
Share
View Full Paper